UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Annals of oncology, 2012-06, Vol.23 (6), p.1555-1561

2012

Volltextzugriff (PDF)

Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia

Annals of oncology, 2012-09, Vol.23 (9), p.2386-2390

2012

Volltextzugriff (PDF)

Paraneoplastic Acute Diffuse Encephalitis Revealing Hodgkin's Disease

Leukemia & lymphoma, 2004-12, Vol.45 (12), p.2509-2512

2004

Volltextzugriff (PDF)

PS993 DE NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS DISPLAY AT DIAGNOSIS FUNCTIONAL DEREGULATION OF REDOX BALANCE CORRELATED WITH MOLECULAR SUBTYPES AND OVERALL SURVIVAL

HemaSphere, 2019-06, Vol.3 (S1), p.446-447

2019

Volltextzugriff (PDF)

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Haematologica (Roma), 2010-06, Vol.95 (6), p.892-899

2010

Volltextzugriff (PDF)

Bortezomib + Low Dose Cytarabine in Int-2 and High Risk MDS. Interim Results of a Phase I/II Trial by the GFM

Blood, 2007-11, Vol.110 (11), p.1453-1453

2007

Volltextzugriff (PDF)

Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia

Annals of oncology, 2012-09, Vol.23 (9), p.2386

2012

Volltextzugriff (PDF)

Value of Early Evaluation with FDG-PET for Follicular Lymphoma

Blood, 2005-11, Vol.106 (11), p.4718-4718

2005

Volltextzugriff (PDF)

One- and Two-Month-Old Dog Puppies Exhibit Behavioural Synchronization with Humans Independently of Familiarity

Animals (Basel), 2022-11, Vol.12 (23), p.3356

2022

Volltextzugriff (PDF)

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study

British journal of haematology, 2013-07, Vol.162 (2), p.240-249

2013

Volltextzugriff (PDF)

Multidisciplinary team meetings in cancerology: setting priorities for improvement

Bulletin du cancer, 2011-10, Vol.98 (9), p.989

2011

Volltextzugriff (PDF)

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study

Blood, 2019-11, Vol.134 (Supplement_1), p.494-494

2019

Volltextzugriff (PDF)

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

Blood, 2014-12, Vol.124 (21), p.3070-3070

2014

Volltextzugriff (PDF)

Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab

Leukemia & lymphoma, 2010-01, Vol.51 (1), p.174-177

2010

Volltextzugriff (PDF)

High Intermittent Dose of Chlorambucil Associated with Rituximab Is a Promising Treatment of Elderly Patients with Indolent Lymphoma

Blood, 2009-11, Vol.114 (22), p.4761-4761

2009

Volltextzugriff (PDF)

Two New α-Thalassemia Point Mutations that are Undetectable by Biochemical Techniques

Hemoglobin, 2008-01, Vol.32 (4), p.411-417

2008

Volltextzugriff (PDF)

Érythropoïétine (EPO) et anémie en soins palliatifs chez le patient atteint de cancer

Médecine palliative, 2007-10, Vol.6 (5), p.274-284

2007

Volltextzugriff (PDF)

Pathologie avancée et défaillances d’organes : outil d’aide à la décision

Médecine palliative, 2014-06, Vol.13 (3), p.150-154

2014

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(45)
Berichte
(3)
Reviews
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(9)
Hematology
(7)
Female
(5)
Male
(5)
Oncology
(5)
Adult
(4)
Aged
(4)
Biological And Medical Sciences
(4)
Hematologic And Hematopoietic Diseases
(4)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(4)
Medical Sciences
(4)
Treatment Outcome
(4)
Aged, 80 And Over
(3)
Antineoplastic Agents
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Life Sciences
(3)
Middle Aged
(3)
Rituximab
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia

Paraneoplastic Acute Diffuse Encephalitis Revealing Hodgkin's Disease

PS993 DE NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS DISPLAY AT DIAGNOSIS FUNCTIONAL DEREGULATION OF REDOX BALANCE CORRELATED WITH MOLECULAR SUBTYPES AND OVERALL SURVIVAL

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Bortezomib + Low Dose Cytarabine in Int-2 and High Risk MDS. Interim Results of a Phase I/II Trial by the GFM

Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia

Value of Early Evaluation with FDG-PET for Follicular Lymphoma

One- and Two-Month-Old Dog Puppies Exhibit Behavioural Synchronization with Humans Independently of Familiarity

Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study)

Treatment-Free Remissions in Newly Diagnosed CP CML Patients Treated with the Combination of Nilotinib + Pegylated Interferon Alpha 2a Versus Nilotinib Alone in the National Phase III Petals Trial

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study

Multidisciplinary team meetings in cancerology: setting priorities for improvement

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study

First-Line Second Generation Tyrosine Kinase Inhibitors in Newly Diagnosed Accelerated Phase Chronic Myeloid Leukemia Patients

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

Combination of Dasatinib and Peg-Interferon Alpha 2b in Chronic Phase Chronic Myeloid Leukemia (CP-CML) First Line: Preliminary Results of a Phase II Trial, from the French Intergroup of CML (Fi-LMC)

High Response Rate and Low Toxicity of Rituximab, Vinorelbine, Ifosfamide, Mitoxantrone and Prednisone Combination for the Treatment of Diffuse Large B Cell Lymphoma In First Relapse: Early Results of the R-NIMP GOELAMS Study

Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab

High Intermittent Dose of Chlorambucil Associated with Rituximab Is a Promising Treatment of Elderly Patients with Indolent Lymphoma

Two New α-Thalassemia Point Mutations that are Undetectable by Biochemical Techniques

Érythropoïétine (EPO) et anémie en soins palliatifs chez le patient atteint de cancer

Pathologie avancée et défaillances d’organes : outil d’aide à la décision

Aktive Filter

Suchergebnisse filtern